Skip to main content
. 2020 May 23;9(5):1588. doi: 10.3390/jcm9051588

Table 1.

Characteristics of the perimenopausal ERMA baseline population (n = 234).

Early Perimenopausal
(n = 89) #
Late Perimenopausal
(n = 145) ¤
P
Age, y 51.2 ± 2.0 51.8 ± 1.8 0.013 a
E2, nmol/L 0.46 ± 0.34 0.26 ± 0.18 <0.001 b
FSH, IU/L 18.3 ± 5.0 46.9 ± 20.6 <0.001 b
DHEAS, µmol/L 2.64 ± 1.42 2.91 ± 1.36 0.135 b
SHBG, nmol/L 58.5 ± 24.3 53.1 ± 22.3 0.140 b
Education level
Primary
Secondary
Tertiary

1.1%
59.1%
39.8%

3.4%
47.6%
49.0%
0.261 b
Smoking
Never
Quitter
Current smoker

74.2%
23.6%
2.2%

66.9%
24.1%
9.0%
0.159 b
Alcohol use, units/week 4.5 ± 4.5 3.9 ± 3.2 0.528 b
Bleeding status
Natural
IUC
Hysterectomy

56.2%
34.8%
9.0%

66.9%
29%
4.1%
0.151 c
Physical activity
MVPA, min/day X 53.6 ± 22.8 52.0 ± 32.9 0.195 b
MET-hours/day XX 4.6 ± 4.2 4.3 ± 3.8 0.743 b

Values are given as mean ± SD or as percentage. DHEAS, sulfated dehydroepiandrosterone; E2, estradiol; FSH, follicle stimulating hormone; IUC, intra-uterine contraception/progestogen use; MET, metabolic equivalent; MVPA, moderate-to-vigorous physical activity; SHBG, sex hormone binding globulin.# In the early perimenopausal group, there are missing data regarding education, alcohol use and MET-h/day (n = 1) and regarding MVPA (n = 21). ¤ In the late perimenopausal group, there are missing data regarding DHEAS and SHBG (n = 1) and MVPA (n = 21). a Independent samples t-test, b Mann–Whitney U-test, c Chi-squared test, X accelerometer-measured, XX self-reported. Significant results (P ≤ 0.050) are shown in bold.